Wolverine Trading
AUPH icon

Wolverine Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wolverine Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-80,600
Closed -$696K – 5618
2025
Q2 		$696K Sell
80,600
-3,500
-4% -$28.1K ﹤0.01% 2648
2025
Q1 		$697K Sell
84,100
-16,800
-17% -$136K ﹤0.01% 2593
2024
Q4 		$925K Buy
100,900
+18,800
+23% +$153K ﹤0.01% 2737
2024
Q3 		$598K Buy
+82,100
New +$509K ﹤0.01% 2886
2024
Q2 		– Sell
-79,700
Closed -$399K – 4457
2024
Q1 		$399K Sell
79,700
-108,000
-58% -$733K ﹤0.01% 3068
2023
Q4 		$1.69M Buy
+187,700
New +$1.55M ﹤0.01% 1834
2023
Q3 		– Sell
-160,300
Closed -$1.47M – 4478
2023
Q2 		$1.47M Sell
160,300
-9,300
-5% -$96.5K ﹤0.01% 1700
2023
Q1 		$1.86M Buy
169,600
+24,600
+17% +$217K ﹤0.01% 1416
2022
Q4 		$626K Buy
+145,000
New +$841K ﹤0.01% 2181
2022
Q2 		– Sell
-180,000
Closed -$2.23M – 4471
2022
Q1 		$2.23M Sell
180,000
-2,100
-1% -$32.5K ﹤0.01% 1669
2021
Q4 		$4.15M Sell
182,100
-3,600
-2% -$85.3K ﹤0.01% 1272
2021
Q3 		$4.27M Buy
+185,700
New +$2.95M ﹤0.01% 1430

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's AUPH Position: Q2 2025 in Review

Wolverine Trading sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 19,374 shares — an estimated $155K sold.

Wolverine Trading first reported a position in AUPH in Q3 2021 and held it in 6 quarters. The position peaked at $1.5M in Q3 2024. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • Wolverine Trading reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 19,374 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $155K.
  • Wolverine Trading first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Wolverine Trading's Aurinia Pharmaceuticals position peaked at $1.5M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.